SCIRENT, a full-service cardiovascular Contract Research Organization (CRO) specializing in clinical studies for heart failure and cardiac devices, will participate in the upcoming CSI Focus D-HF 2025, taking place December 5–6, 2025, in Frankfurt, Germany. The conference is the leading international meeting dedicated to device-based therapy for heart failure, bringing together experts from clinical practice, research, and industry.
This year’s CSI Focus D-HF will highlight the latest advances in ventricular restoration, cardiac support, telemedicine, and emerging monitoring technologies that are transforming the landscape of heart-failure treatment. Sessions will explore the balance between device-based and medical therapy, innovations in interatrial shunting, and new frontiers such as microcurrent therapy.
With its deep expertise in heart-failure device trials and cardiovascular research, SCIRENT looks forward to engaging with thought leaders, sharing insights, and contributing to discussions shaping the future of heart-failure care. SCIRENT remains committed to advancing innovation in cardiovascular medicine through scientifically rigorous, patient-centered clinical research.